Design & evaluation of new devices for radiation dose delivery in brachytherapy
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2020/03/023701
- Lead Sponsor
- Department of Radiotherapy Radiation Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Histo-pathologically confirmed patients of carcinoma of the uterine cervix
2. FIGO stage IB2 to stage IVA
3. Patients who will give approved informed consent
Exclusion Criteria
1.FIGO stage IVA with Vesicovaginal or recto-vaginal fistula and IVB cervical cancer
2.Previous history of pelvic irradiation
3.Post hysterectomy carcinoma cervix cases
4.Patients not completed planned treatment schedules
Pregnant women or lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We expect that as compare to commercially available applicator our applicator will have zero perforation, No artifacts on CT imaging. <br/ ><br>We Will evaluate the outcome in terms of toxicity and response. <br/ ><br>Timepoint: One year after completion of treatment.
- Secondary Outcome Measures
Name Time Method ATimepoint: NA